Articles
Lung cancer screening: 2022 could be a turning point for Europe
If cancer screening policies were driven purely by mortality rates and curability, then lung cancer would long have topped the priority list for population screening programmes. Accounting for almost one…
Tackling drug resistance: how our commensal bacteria can hinder or help
Response to therapeutics can differ widely from patient to patient, with some gaining highly significant survival benefits from a therapy that in others elicits no response at all. Patients who…
Evolution of the doctor-patient relationship: from ancient times to the personalised medicine era
The nature of the doctor–patient relationship has gone through various phases in history, based on the changing role of the physician in the community, as well as progress in medicine…
Informal carers play a key role in cancer care: they need and deserve more support
What is it worth to patients to have someone they can rely on to provide emotional support and talk things through, help them get to and from appointments, remind them…
Liver cancer: how Europe can halt the rising death toll
When the cancer community in Europe talks of neglected cancers it usually means relatively rare or uncommon types, of which there are many. But conspicuous in the list are two…
Drugs shortages: ‘We parents of children with cancer are too exhausted to protest’
When it all started, Ioana Oprea did not have a spare moment to come to terms with what had happened ‒ to truly take in the fact that her son…
North and South ‒ learning faster means learning together
When you look at the vast waiting area in Mumbai’s world leading Tata Memorial Cancer Hospital, pictured above, what do you see? A crowded chaotic scene where sick patients and…
Woman or man? Is precision medicine overlooking key biological differences?
“Something that hit me pretty early during my residency as an oncologist was that sex in most cases is a clear-cut binary, pretty obvious biological variable affecting attitudes as well…
Surviving childhood cancer: how we standardise care across Europe
When Lejla Kameric’s daughter was treated for non-Hodgkin’s lymphoma, the twelve-year-old had to get through lumbar punctures without pain relief. “15 years ago in Bosnia, painful procedures and diagnostic activities…
The development of organoids for cancer research: an ode to the scientific method
Some twenty years ago, I sailed with my two little sons Sander (aged 7) and Max (aged 5) on the Ijsselmeer, formerly a large inner sea in the centre of…